ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,577Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 17

$520K Total Retail Price of All Prescriptions

Rank: 6 out of 17

387 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

7% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 8,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
LEVOTHYROXINE SODIUM 423 423 1 1
SIMVASTATIN 379 372 2 5
OMEPRAZOLE 352 352 3 9
FUROSEMIDE 271 258 4 2
LISINOPRIL 261 260 5 3
AMLODIPINE BESYLATE 237 237 6 6
METOPROLOL TARTRATE 194 192 7 7
WARFARIN SODIUM 190 190 8 4
TRAMADOL HCL 176 164 9 21
LIDODERM 159 149 10 18
GABAPENTIN 159 159 10 10
METOPROLOL SUCCINATE 139 139 12 11
ALENDRONATE SODIUM 136 136 13 31
HYDROCHLOROTHIAZIDE 133 133 14 24
ATORVASTATIN CALCIUM 129 129 15 20
ATENOLOL 120 120 16 19
ZOLPIDEM TARTRATE 120 120 16 64
HYDROCODONE-ACETAMINOPHEN 106 105 S3 18 33
SERTRALINE HCL 106 99 18 22
POTASSIUM CHLORIDE 100 100 20 23
PANTOPRAZOLE SODIUM 99 99 21 39
DONEPEZIL HCL 94 94 22 8
TRAZODONE HCL 85 85 23 17
MIRTAZAPINE 84 84 24 13
SPIRONOLACTONE 82 82 25 63
MELOXICAM 81 69 26 43
ESCITALOPRAM OXALATE 81 72 26 28
NAMENDA 77 75 28 12
METFORMIN HCL 73 73 29 29
OXYCODONE HCL 69 69 S2 30 88
FLUTICASONE PROPIONATE 62 62 31 66
CRESTOR 62 62 31 81
CITALOPRAM HBR 61 57 33 14
LACTULOSE 60 48 34 62
SINGULAIR 60 60 34 109
EXELON 56 56 36 53
PREDNISONE 55 55 37 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.